The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global medical imaging market size reached US$ 37.26 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 54.15 Billion by 2027, exhibiting a growth rate (CAGR) of 6.20% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Medical imaging refers to the technique of creating visual depictions of the human body for diagnosing an ailment and its subsequent medical treatment. Computed tomography (CT) scanners, magnetic resonance imaging (MRI), nuclear imaging, mammography, and ultrasound are common medical imaging systems. It is a non-invasive technique that helps medical professionals to assess patients' bones, organs, tissue, and blood vessels. Medical imaging tests are safe, quick, and easy to perform and aid in early and accurate diagnosis, understanding complications, and eliminating the need for exploratory surgery. As a result, medical imaging is widely used in cardiovascular and thoracic, orthopedics and musculoskeletal, obstetrics and gynecology, and neurology departments.
The significant growth in the healthcare industry across the globe is creating a positive outlook for the market. In line with this, the growing occurrence of lifestyle diseases owing to sedentary lifestyles and age-related ailments in the steadily rising geriatric population is also favoring the market growth. Medical imaging is widely used by healthcare specialties to diagnose diseases and injuries, such as cancer, heart blockage, fractures, and tumors. Apart from this, the introduction of three-dimensional (3D) imaging technology to develop enhanced resolutions and more intricate details for better patient care is providing an impetus to the market growth. Moreover, the integration of artificial intelligence (AI) to enhance tissue-based detection and provide accuracy and sensitivity in the identification of imaging abnormalities is acting as another growth-inducing factor. Furthermore, the increasing demand for CT scans and MRIs to detect the spread of COVID-19 in the lungs is positively influencing the market growth. Other factors, including rising expenditure capacities of consumers, extensive research and development (R&D) activities, and the launch of portable imaging devices, are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical imaging market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end user.
Breakup by Product:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Canon Medical Systems Corporation (Canon Inc.), Carestream Health, Cubresa Inc., Esaote SpA, FUJIFILM VisualSonics Inc., GE HealthCare (General Electric Company), Hologic Inc., Koning Corporation, Koninklijke Philips N.V., Materialise NV, Mindray Medical International Limited, Samsung Medison Co. Ltd. (Samsung Electronics Co. Ltd.) and Siemens Healthineers AG (Siemens AG).
|Base Year of the Analysis||2021|
|Segment Coverage||Product, Application, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Canon Medical Systems Corporation (Canon Inc.), Carestream Health, Cubresa Inc., Esaote SpA, FUJIFILM VisualSonics Inc., GE HealthCare (General Electric Company), Hologic Inc., Koning Corporation, Koninklijke Philips N.V., Materialise NV, Mindray Medical International Limited, Samsung Medison Co. Ltd. (Samsung Electronics Co. Ltd.) and Siemens Healthineers AG (Siemens AG).|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Blockchain in Healthcare Market by Network Type (Private, Public, and Others), Application (Supply Chain Management, Data Exchange and Interoperability, Claims Adjudication and Billing Management, and Others), End Use (Healthcare Providers, Healthcare Payers, Biopharmaceutical & Medical Device Companies, and Others), and Region 2023-2028
Disinfection Robots Market by Product Type (UV-Disinfection Robot, Hydrogen Peroxide Vaporization Robot (HPV), and Others), Technology (Fully Autonomous Disinfection Robots, Semi-Autonomous Disinfection Robots), End User (Hospitals and Clinics, Research Institutes, and Others), and Region 2023-2028
Remote Healthcare Market by Service (Remote Patient Monitoring, Real Time Virtual Health, Tele-ICU), Application (Diagnosis, Cardiology, Obstetrics, Senior Care, and Others), End User (Payer, Provider, Patient, Employer Groups and Government Organizations), and Region 2023-2028
Medication Management Market by Software (Computerized Physician Order Entry System, Clinical Decision Support System, Administration Software, Inventory Management System, Automated Dispensing Systems, Assurance System), Services (Medication Analytics Services, Point-Of-Care Verification Services, Adverse Drug Event (ADE) Surveillance Services), Mode of Delivery (Web-based, Cloud-based, On-premises), End User (Pharmacies, Hospitals and Others) and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at